Activation state (phosphorylated) EGFR and STAT3 as prognostic markers in resected non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Cortas, T [1 ]
Eisenberg, R [1 ]
Fu, P [1 ]
Robke, J [1 ]
Kern, JA [1 ]
Dowlati, A [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：642S / 642S
页数：1
相关论文
共 50 条
  • [21] TUMOR ENDOTHELIAL MARKERS (TEMS) AS PROGNOSTIC AND PREDICTIVE MARKERS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Pircher, A.
    Untergasser, G.
    Heidegger, I. M.
    Kern, J.
    Gunsilius, E.
    Fiegl, M.
    Hilbe, W.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
  • [22] Epidermal growth factor receptor mutations and stat3 phosphorylation in surgically resected non-small cell lung cancer
    Yang, F.
    Zhou, Z.
    Wang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC) - Maspin in NSCLC
    Katakura, H
    Takenaka, K
    Nakagawa, M
    Sonobe, M
    Adachi, M
    Ito, S
    Wada, H
    Tanaka, F
    LUNG CANCER, 2006, 51 (03) : 323 - 328
  • [24] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Kim, Seung Tae
    Sung, Jae Sook
    Jo, Uk Hyun
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Yeul Hong
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [25] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Seung Tae Kim
    Jae Sook Sung
    Uk Hyun Jo
    Kyong Hwa Park
    Sang Won Shin
    Yeul Hong Kim
    Medical Oncology, 2013, 30
  • [26] CAN MUTATIONS OF EGFR AND KRAS OF SERUM BE PREDICTIVE AND PROGNOSTIC MARKERS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)?
    Kim, S. T.
    Kim, Y. H.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S66 - S66
  • [27] Prognostic factors in resected Stage I and II non-small lung cancer (NSCLC)
    Mauro, Laura V.
    Dallurzo, Liliana
    Smith, David
    Veloso, Maria J.
    Lastiri, Jose
    Vasallo, Bartolome
    Pallotta, Maria G.
    de Kier Joffe, Elisa D. Bal
    Puricelli, Lydia
    CANCER RESEARCH, 2006, 66 (08)
  • [28] Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer
    Ai, Ting
    Wang, Zhouquan
    Zhang, Mingxin
    Zhang, Lingmin
    Wang, Ning
    Li, Weiwei
    Song, Liping
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (02): : E132 - E138
  • [29] Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells
    Yin, Zhenjie
    Zhang, Yan
    Li, Yu
    Lv, Tingting
    Liu, Jie
    Wang, Xinbo
    ACTA HISTOCHEMICA, 2012, 114 (02) : 151 - 158
  • [30] The role of STAT3 (Signal Transducer and Activator of Transcription protein-3) in non-small cell lung cancer (NSCLC)
    Heim, Lisanne
    Finotto, Susetta
    CYTOKINE, 2015, 76 (01) : 97 - 97
12345